| Profile | GDS1873 / 201938_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 4080.56 | 98 |
| GSM40788 | control - Rep 2 | 2049.25 | 95 |
| GSM40789 | control - Rep 3 | 3460.96 | 97 |
| GSM40775 | androgen treated - Rep 1 | 2808.43 | 97 |
| GSM40776 | androgen treated - Rep 2 | 3851.38 | 98 |
| GSM40777 | androgen treated - Rep 3 | 3220.57 | 97 |
| GSM40790 | estrogen treated - Rep 1 | 2880.53 | 97 |
| GSM40791 | estrogen treated - Rep 2 | 3974.83 | 98 |
| GSM40792 | estrogen treated - Rep 3 | 4096.38 | 98 |
| GSM40784 | A + tamoxifen - Rep 1 | 3384.97 | 97 |
| GSM40785 | A + tamoxifen - Rep 2 | 3384.92 | 97 |
| GSM40786 | A + tamoxifen - Rep 3 | 3899.5 | 98 |
| GSM40778 | A + anastrozole - Rep 1 | 2858.36 | 97 |
| GSM40779 | A + anastrozole - Rep 2 | 3685.41 | 97 |
| GSM40780 | A + anastrozole - Rep 3 | 3651.25 | 97 |
| GSM40781 | A + letrozole - Rep 1 | 2023.1 | 96 |
| GSM40782 | A + letrozole - Rep 2 | 3159.78 | 97 |
| GSM40783 | A + letrozole - Rep 3 | 4195.98 | 98 |